Video & Transcript Research : 'R.S. 14:313.2'

Page 1 of 500
KY
Transcript Highlights:
  • :14:04.160> patients<00:14:04.560> that<00:14:04.680> we<00:14:04.839> serve<
  • <00:14:05.880> option<00:14:06.120> to<00:14:06.279> drive<00:14:06.600>
  • > many<00:14:11.519> days<00:14:11.759> per week<00:14:16.120> with<00:14
  • c><00:14:20.720> no<00:14:20.959> way<00:14:21.199> that<00:14:21.480> we
  • patients locally<00:14:41.440> and<00:14:41.600> also<00:14:41.880> help<00:14:
Summary: The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions. The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill. Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.
KY
Transcript Highlights:
  • ><00:14:02.600> remove<00:14:03.240> based<00:14:03.519> upon<00:14:03.759> the
  • 189 a005<00:14:09.839> why<00:14:10.040> do<00:14:10.759> what<00:14:10.839>
  • <00:14:31.320> thank you<00:14:38.440> so<00:14:38.680> we<00:14:38.800>
  • do<00:14:39.120> have<00:14:39.639> U<00:14:40.199> testimony<00:14:40.759><
  • > and<00:14:43.199> that<00:14:43.399> is<00:14:43.839> uh<00:14:44.079><
Summary: The House Judiciary Committee met with a full roll call and first took up House Bill 220, which would strengthen Kentucky DUI penalties. The sponsor and a Commonwealth’s attorney testified that the bill would make a third DUI within 10 years a felony, while keeping first- and second-offense penalties the same, and that the committee substitute also adds escalating fines for under-21 DUI offenses and aligns interlock requirements. Supporters argued the change is needed to protect families and respond to repeat impaired driving, citing a fatal case involving a young victim and a repeat offender with a high blood alcohol level and prior DUI convictions. Members asked about treatment, sentencing, and drafting details. The sponsor explained that the existing mandatory substance-abuse treatment requirement for fourth-or-greater offenses would apply to third-or-greater offenses under the substitute, and that a 120-day minimum remains in place. Questions were also raised about removing redundant statutory language and about whether felony treatment could sometimes result in less actual jail time than a misdemeanor; the sponsor and prosecutor said such cases are rare and that the bill gives prosecutors and juries more tools. Representative Blanton supported the bill but noted it does not address fentanyl, and the sponsor said he has a separate bill for that issue. Opposition testimony came from Scott West of the Kentucky Association of Criminal Defense Lawyers, who said he supported tougher DUI enforcement but opposed felonyizing the third offense. He argued that the current system already imposes mandatory jail and treatment, that felony cases often resolve through plea bargains with parole eligibility that may not increase actual time served, and that the better approach would be stronger mandatory counseling, longer license suspensions, and ignition interlock requirements rather than felony status. After discussion, the committee adopted the committee substitute and passed HB 220 favorably by a 19-0 vote. The committee then began House Bill 136, which would require the Department of Corrections to compile and submit annual reports to the General Assembly on corrections and parole outcomes, including time served and supervision data. The sponsor and a witness from the Georgia Center for Opportunity said the bill is intended to improve transparency and give lawmakers better data for policy decisions. Members voiced support for better post-release data and asked whether DOC could implement the reporting; the witness said DOC had not expressed concerns and already submits some reports. Discussion on HB 136 was underway when the transcript ended.
VA

Virginia 2026 1st Special Session

March 14, 2026 - Regular Session

Virginia House Floor Meeting

VA

Virginia 2026 1st Special Session

March 14, 2026 - Regular Session Part 2

Virginia House Floor Meeting

Transcript Highlights:
  • Over on page 14 in the printed calendar, we come to House Bill 2011.
  • Over on page 14 in the printed calendar, we come to House Bill 2011. calendar.
VA

Virginia 2026 1st Special Session

March 14, 2026 - Regular Session Part 3

Virginia House Floor Meeting

VA

Virginia 2026 1st Special Session

March 14, 2026 - Regular Session Part 4

Virginia House Floor Meeting